Considering that the role of TREM2 changes during the development of AD, being positive in the early stages and negative in the late stages, down-regulation of Trem2 expression by the inhibition of BET family proteins might have a beneficial effect only in the late stage of AD. This evidence concerns the gene DNER and Alzheimer disease.